Graph Database :: Data Schema
Graph Database :: Data Schema
-
DatabaseObject
- AbstractModifiedResidue [51759]
-
Affiliation
[335]
-
CatalystActivity
[37704]
- ControlReference [2729]
- ControlledVocabulary [14]
-
DatabaseIdentifier
[720031]
-
EntityFunctionalStatus
[683]
- Event [111908]
- ExternalOntology [958]
-
Figure
[873]
-
FunctionalStatus
[27]
-
FunctionalStatusType
[5]
- GO_Term [3004]
-
InstanceEdit
[124179]
- Interaction [54236]
-
NegativePrecedingEvent
[313]
-
Person
[156101]
-
PhysicalEntity
[389298]
-
Cell
[5]
-
Complex
[101725]
-
Drug
[1129]
-
ChemicalDrug
[1038]
-
ProteinDrug
[90]
-
RNADrug
[1]
-
ChemicalDrug
[1038]
- EntitySet [43152]
- GenomeEncodedEntity [237682]
-
OtherEntity
[347]
-
Polymer
[1504]
-
SimpleEntity
[3754]
-
Cell
[5]
- Publication [38727]
-
ReferenceDatabase
[148]
- ReferenceEntity [739543]
- Regulation [6937]
-
Summation
[20052]
- Taxon [391]
Entries: Pathway
Select species:
| Identifier | Name |
|---|---|
| R-HSA-5362517 | Signaling by Retinoic Acid |
| R-HSA-194315 | Signaling by Rho GTPases |
| R-HSA-9716542 | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
| R-HSA-1433557 | Signaling by SCF-KIT |
| R-HSA-5339700 | Signaling by TCF7L2 mutants |
| R-HSA-170834 | Signaling by TGF-beta Receptor Complex |
| R-HSA-3304351 | Signaling by TGF-beta Receptor Complex in Cancer |
| R-HSA-9006936 | Signaling by TGFB family members |
| R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
| R-HSA-194138 | Signaling by VEGF |
| R-HSA-195721 | Signaling by WNT |
| R-HSA-4791275 | Signaling by WNT in cancer |
| R-HSA-1839122 | Signaling by activated point mutants of FGFR1 |
| R-HSA-1839130 | Signaling by activated point mutants of FGFR3 |
| R-HSA-1839117 | Signaling by cytosolic FGFR1 fusion mutants |
| R-HSA-9673766 | Signaling by cytosolic PDGFRA and PDGFRB fusion proteins |
| R-HSA-9680187 | Signaling by extracellular domain mutants of KIT |
| R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants |
| R-HSA-9669935 | Signaling by juxtamembrane domain KIT mutants |
| R-HSA-9669933 | Signaling by kinase domain mutants of KIT |
| R-HSA-9673768 | Signaling by membrane-tethered fusions of PDGFRA or PDGFRB |
| R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants |
| R-HSA-9670439 | Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants |
| R-HSA-8853336 | Signaling by plasma membrane FGFR1 fusions |
| R-HSA-983705 | Signaling by the B Cell Receptor (BCR) |
| R-HSA-9649948 | Signaling downstream of RAS mutants |
| R-HSA-198765 | Signalling to ERK5 |
| R-HSA-187687 | Signalling to ERKs |
| R-HSA-167044 | Signalling to RAS |
| R-HSA-198745 | Signalling to STAT3 |
| R-HSA-187706 | Signalling to p38 via RIT and RIN |
| R-HSA-426486 | Small interfering RNA (siRNA) biogenesis |
| R-HSA-445355 | Smooth Muscle Contraction |
| R-HSA-427652 | Sodium-coupled phosphate cotransporters |
| R-HSA-433137 | Sodium-coupled sulphate, di- and tri-carboxylate transporters |
| R-HSA-425561 | Sodium/Calcium exchangers |
| R-HSA-425986 | Sodium/Proton exchangers |
| R-HSA-9824272 | Somitogenesis |
| R-HSA-9669936 | Sorafenib-resistant KIT mutants |
| R-HSA-9674404 | Sorafenib-resistant PDGFR mutants |
| R-HSA-9827857 | Specification of primordial germ cells |
| R-HSA-9834899 | Specification of the neural plate border |
| R-HSA-1300642 | Sperm Motility And Taxes |
| R-HSA-9845614 | Sphingolipid catabolism |
| R-HSA-1660661 | Sphingolipid de novo biosynthesis |
| R-HSA-428157 | Sphingolipid metabolism |
| R-HSA-1295596 | Spry regulation of FGF signaling |
| R-HSA-69541 | Stabilization of p53 |
| R-HSA-211994 | Sterols are 12-hydroxylated by CYP8B1 |
| R-HSA-211736 | Stimulation of the cell death response by PAK-2p34 |
| R-HSA-2672351 | Stimuli-sensing channels |
| R-HSA-390522 | Striated Muscle Contraction |
| R-HSA-1614517 | Sulfide oxidation to sulfate |
| R-HSA-1614635 | Sulfur amino acid metabolism |
| R-HSA-9669934 | Sunitinib-resistant KIT mutants |
© 2024 Reactome
